In addition, several studies demonstrated that CD133+CD44+ cells exhibited much higher invasion and migratory capacities in vitro than a non-CCSC subset and drove tumor metastasis formation in vivo [23, 24]. The gene discussed is PROM1; the disease is neoplasm.